ADMA250117P21000
- 2.81
- 0.000.00%
ADMA Biologics Newsroom
ADMA Biologics to Participate in the J.P. Morgan Healthcare Conference on January 13, 2025
Will Weakness in ADMA Biologics, Inc.'s (NASDAQ:ADMA) Stock Prove Temporary Given Strong Fundamentals?
Why Is ADMA Biologics, Inc. (ADMA) Among the Best Multibagger Stocks to Buy Right Now?
The Zacks Analyst Blog Highlights ADMA Biologics, Tarsus Pharmaceuticals, Stoke Therapeutics, Inc. and ChromaDex
4 Drug, Biotech Stocks Rising More Than 50% in 2024 With Room to Grow
ADMA Biologics Announces Partial Paydown of Senior Term Loan Credit Facility
4 Biotech Stocks Most Wall Street Analysts Are Bullish About
Mizuho Securities Maintains ADMA Biologics(ADMA.US) With Buy Rating, Announces Target Price $28
Express News | ADMA Biologics Inc : Mizuho Raises Target Price to $28 From $24
ADMA Stock Falls 19% From Its 52-Week High: Should You Buy the Dip?
Looking Into ADMA Biologics's Recent Short Interest
Can Adma Biologics (ADMA) Climb 25.5% to Reach the Level Wall Street Analysts Expect?
Mizuho Securities Maintains ADMA Biologics(ADMA.US) With Buy Rating
10 Health Care Stocks With Whale Alerts In Today's Session
ADMA Biologics (NASDAQ:ADMA) Seems To Use Debt Quite Sensibly
Adma Biologics (ADMA) Is on the Move, Here's Why the Trend Could Be Sustainable
Insider Sale: CFO and Treasurer of $ADMA (ADMA) Sells 15,000 Shares
ADMA Biologics Announces Board Resignations and Appointments
Mizuho Securities Maintains ADMA Biologics(ADMA.US) With Buy Rating, Maintains Target Price $24
Brokers Suggest Investing in Adma Biologics (ADMA): Read This Before Placing a Bet